Clinical trials in Israel decline sharply

Medical research  credit: Shutterstock
Medical research credit: Shutterstock

Revenue from trials by international companies in Israeli hospitals fell to NIS 518 million in 2023 from NIS 818 million in 2022.

Clinical trials carried out by international companies in Israel declined sharply in 2023, according to a report by the Ministry of Health. In recent years, such trials have contributed a large part of the revenue of Israeli hospitals. They are also important in giving patients access to the most up-to-date technologies, and for maintaining the international status of Israeli doctors and training them in the use of the newest products.

In 2022, Israeli hospitals derived NIS 818 million revenue from clinical trials, but in 2023 the figure was only NIS 518 million. Besides the war that broke out at the beginning of the fourth quarter of last year, and the effect of the judicial reform program, the decline was because of a global decline in biomedical research that year.

The revenue from clinical trials in 2023 was the lowest since 2014, but the negative trend began in 2022, when revenue was down 15% in comparison with 2021, a record year for clinical trials. The period 2020-2021 saw peak activity in global biomedical research, and was especially successful for clinical trials in Israel thanks to collaborative efforts on the Covid-19 virus. The positioning of Israel’s health system as a good source of data in view of its response to the pandemic helped to attract clinical trials in other fields as well. But, as mentioned, the charm began to wear off in 2022, and the situation worsened in 2023.

The hospital with the highest revenue from clinical trials in 2023 was Sheba, which also headed the list in 2022. Rambam was second, while Ichilov was fifth in 2023 after leading the table in 2021.

Merck & Co., Inc. was by some way the largest investor in clinical trials in Israel in the last three years, but even its investment halved in 2023 in comparison with 2022, from NIS 121 million to NIS 60 million. Other leading companies in this respect were AbbVie, AstraZeneca, Janssen Pharmaceuticals, Eli Lilly, Genentech (Roche), Novartis, Pfizer, and Amgen.

The Ministry of Health document also lists the practitioners who received the highest budgets for clinical trials. The table is headed by oncologist Dr. Ronnie Shapira-Frommer of Sheba Hospital, who led ten studies in 2023 with a combined budget of NIS 9.4 million. She is followed by Prof. Michael Shechter, a heart specialist, also from Sheba; oncologist Dr. Avivit Peer of Rambam Hospital; Dr. Hila Magen, a specialist in hemato-oncology at Sheba; and Prof. Salomon Stemmer, an oncologist at Beilinson Hospital (Rabin Medical Center).

Many doctors have expressed the fear that the continuing war and Israel political status in the world will lead international companies to cease carrying out clinical trials here. There are no figures for 2024 yet, but in fact the hospitals report an improving trend so far in comparison with 2023.

Published by Globes, Israel business news - en.globes.co.il - on June 18, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Medical research  credit: Shutterstock
Medical research credit: Shutterstock
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018